NMRD — Nemaura Medical Share News
0.000.00%
HealthcareHighly SpeculativeMicro Cap
- $0.00m
- $19.51m
- $0.08m
Nemaura Medical Inc reports results for the quarter ended in March - Earnings Summary
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:46 AM
U.S. STOCKS ON THE MOVE-Peloton, Athenex, Boeing
U.S. STOCKS ON THE MOVE-HollyFrontier, Hayward Holdings, Athenex
Nemaura Medical surges on purchase order for glucose monitor
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:59 AM
Brief: Nemaura Medical Announces Order For 200,000 sugarBEAT Sensors
Brief: Nemaura Medical To Report Revenues Related To Sales Of Sugarbeat In UK, Europe
Brief: Nemaura Medical Announces Submission To German Authorities For Reimbursement Of Glucose Monitoring Device
Brief: Nemaura Medical Reports Financial Results For Q3 And Provides Corporate Update
Brief: Nemaura Medical Secures $20 Mln Non-Dilutive Loan To Accelerate Business Growth
Brief: Nemaura Medical Says Co And Certain Units Entered Into A Note Purchase Agreement With Uptown Capital
NASDAQ RESUMED AT 09:47 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:37 AM
Brief: Nemaura Medical Launches Beat Diabetes Program
Brief: Nemaura Medical Reports Quarterly Loss Per Share $0.07
Brief: Nemaura Medical Appoints Justin Mclarney As Chief Finance Officer
Brief: Nemaura Medical Files For Offering Of 1.6 Mln Shares, Warrants To Purchase Up To 793,103 Shares Of Common Stock
Brief: Nemaura Medical Says Each Share & Accompanying One-Half Of A Warrant Being Sold For A Combined Purchase Price Of $7.25, For Gross Deal Size Of $11.5 Mln